ERBB2 and cancer: ERBB2 gene amplification and mutation are generally mutually exclusive, suggesting that they are independent oncogenic drivers of tumorigenesis, and these alterations may be responsible for the different oncogenesis, biological properties, and clinical features of various cancers [5,16].